- RaySearch Laboratories AB (publ) has announced an agreement to collaborate with GE Healthcare (GHCI). These are the details.
RaySearch Laboratories AB (publ) has announced an agreement to collaborate with GE Healthcare (GHCI), the $17.7 billion healthcare business of GE (NYSE: GE), to develop a new radiation therapy simulation and treatment planning workflow solution, designed to make use of the latest advancements in treatment planning technology. The companies are aiming to combine RaySearch’s advanced treatment planning system RayStation with GE Healthcare’s leading multi-modality (CT/MR/molecular imaging) simulator systems to make cancer treatment faster and more precise.
Over 60% of cancer patients undergo radiation therapy according to the US National Institutes of Health, which requires high-quality imaging to precisely target tumors while sparing healthy tissue. The precision imaging is foundational to determining the size, shape, and characteristics of tumors and differentiating between healthy tissues. And a key issue for oncologists can be the cumbersome simulation process and the need to navigate multiple systems and workflows manually. The aim of the collaboration is to simplify this process by enabling point of care decision-making in the simulation room.
GE Healthcare and RaySearch are aiming to enable hospitals and cancer treatment centers to implement an interoperable and integrated workflow that will optimize their clinical planning and operational outcomes. And as providers look to automate radiation oncology processes in the face of increasing numbers of patients and advancements in radiation treatment delivery procedures, GE and RaySearch are working to bring together complementary technologies and solutions in order to advance innovation and help the radiation oncology community.
“GE Healthcare is delighted to be partnering with RaySearch, as we seek to improve precision guidance during radiation therapy planning and treatment. Cancer care can only be improved if those involved work together and this is one of several partnerships that we are pursuing for the benefit of caregivers and patients. Clinicians tell us that navigating through multiple systems to get a clear picture of where cancer cells are is one of their biggest pain points. We are working to bring together complementary solutions and technologies along the radiation therapy treatment pathway to help with this.”
– Jan Makela, President & CEO, Imaging, GE Healthcare
“Software has tremendous potential, and it is now the driving force for innovation in oncology. We are very pleased to be working with a partner with the scale of GE Healthcare, one of the largest providers of precision healthcare, to bring scientific advancements to the clinical world. Our solutions already support thousands of clinics worldwide in the fight against cancer.”
– Johan Löf, founder and CEO, RaySearch Laboratories